Domain: durect.com

Overview
Ads (0)
PPC Keywords (0)
Organic Keywords (26)
Competitors (763)
Sub-Domains
durect.com
Paid Keywords
Keywords found: 0
#Competitors: 0
#Ad Copies: N/A
 
Organic Keywords
Keywords found: 26
#Competitors: 782
Average Position: N/A
 
PPC Overview
No Results Found
Organic Listing Variations
1.
DURECT: Patient Focus
Our goal is to develop pharmaceutical systems that have the potential to be a more convenient, patient-friendly product that provides an alternative to ...
2.
DURECT: Publications
K. Michelle Carraway, Stacey A. Sullivan, Stacey K. Meador, Julie C Williams, John W. Gibson, and Arthur J. Tipton. Presented at the AAPS Midwest Regional ...
3.
DURECT: Nacer E. Dean Abrouk
Nacer E. Dean Abrouk. Prior to joining DURECT, Dr. Abrouk was the Director of Statistics for ALZA Corporation, a Johnson & Johnson subsidiary, ...
4.
DURECT: Publications
Intracranial drug-delivery scaffolds: Biocompatibility evaluation of sucrose .... Meeting of The Controlled Release Society, 1998, June 21-26, Las Vegas, Nevada. ... D.N. Ellis and A.J. Tipton. The 20th Annual Meeting of the Society for ...
5.
DURECT Corporation - Drug delivery technologies treating chronic ...
Sep 22, 2008 ... DURECT Corporation is pioneering the development and commercialization of pharmaceutical drug delivery systems for the treatment of chronic ... Show stock quote for DRRX
6.
DURECT: DURECT Reports Positive Results from POSIDUR Phase IIb ...
Jul 17, 2007 ... In preparation for the Phase III program, DURECT has scheduled an ... DURECT intends to select POSIDUR 5 mL as the dose to use in the Phase ...
7.
DURECT: The SABER Delivery System
The SABER™ Delivery System is a novel controlled-release technology that uses a high-viscosity base, non-polymeric component, such as sucrose acetate ...
8.
DURECT Corporation - Drug delivery technologies treating chronic ...
Sep 22, 2008 ... DURECT Corporation is pioneering the development and commercialization of pharmaceutical drug delivery systems for the treatment of chronic ... Show stock quote for DRRX
9.
DURECT: DURECT Reports Positive Results from POSIDUR Phase IIb ...
Jul 17, 2007 ... In preparation for the Phase III program, DURECT has scheduled an ... DURECT intends to select POSIDUR 5 mL as the dose to use in the Phase ...
10.
SABER Delivery System
File Format: PDF/Adobe Acrobat - View as HTML The SABER Delivery System is a parenteral delivery platform with strong patent .... SABER and the SABER Delivery System are trademarks of DURECT Corporation ...
 
View More »
ascSort Ascending
descSort Descending
eqEquals...
!eqDoes Not Equal...
gtGreater Than...
gteqGreater Than or Equal To...
ltLess Than...
lteqLess Than or Equal To...
      And   Or
                
Sometimes you don’t know exactly what you are looking for in a Research data. That’s when our searching options may come handy.
The Domain Search
This search allows you to enter the domain name of the site you want to analyze. For example, you may enter “amazon.com” in the KeywordSpy search bar.

The Keyword Search
This will let you enter terms and key phrases in the search bar such as “send flowers”, “cover letters”, “keyword software,” and even a single broad term like “chocolate”.

The Ad Copy Search
This allows you to enter any texts or content included in an ad copy, whether the ones in ad copy headline or the ones in description lines. For example: “sunglasses”.
The Destination URL Search
This search allows you to enter the destination URL of the site that you want to analyze.

The destination URL is the address where a searcher is taken when an advertisement copy in search engines is clicked. Please take note that the destination URL differs from the display URL which appears at the bottom of advertisement copies.

Please be reminded to always include http:// at the beginning of your Destination URL search. For example: “http://www.proflowers.com”.

In addition, if you want to find all the ads that KeywordSpy indexed for a specific affiliate network e.g. Hydra Network. You should search in Destination URL the string lynxtrack.com.
Loading
  Loading...